The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas
Abstract
Somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone, inhibits basal insulin secretion in fasted cats and rats. In fasted baboons both basal and arginine-stimulated secretion of insulin and glucagon are inhibited. Somatostatin appears to act directly on the endocrine pancreas. The action is dose-related, rapid in onset, and readily reversed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,199
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
Physiology of Insulin In Man: The Banting Memorial Lecture 1971
Cahill, G. F. (1971) · Diabetes · doi:10.2337/diab.20.12.785 · Cited by 356
ACTION OF GROWTH-HORMONE-RELEASE INHIBITORY HORMONE IN HEALTHY MEN AND IN ACROMEGALY
HALL, R. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92413-6 · Cited by 289
Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method
Cowan, J. S., & Hetenyi, G. (1971) · Metabolism · doi:10.1016/0026-0495(71)90098-9 · Cited by 240
Glycogen Synthetase Activity in Liver: Regulation by the Autonomic Nerves
Shimazu, T. (1967) · Science · doi:10.1126/science.156.3779.1256 · Cited by 150
Role of Insulin in the Hepatic Handling of Glucose
Madison, L. L. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130066010 · Cited by 110
Use of Benzamidine as a Proteolytic Inhibitor in the Radioimmunoassay of Glucagon in Plasma
Ensinck, J. W., Shepard, C., Dudl, R. J., & Williams, R. H. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-35-3-463 · Cited by 94
Self-citation
Cited by
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
The essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
Somatostatin Cell Processes as Pathways for Paracrine Secretion
Larsson, L.-I., Goltermann, N., de Magistris, L., Rehfeld, J. F., & Schwartz, T. W. (1979) · Science · doi:10.1126/science.382360 · Cited by 511
Peptides in the Brain: The New Endocrinology of the Neuron
Guillemin, R. (1978) · Science · doi:10.1126/science.212832 · Cited by 485
Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and Pancreas
Arimura, A., Sato, H., Dupont, A., Nishi, N., & Schally, A. V. (1975) · Science · doi:10.1126/science.56779 · Cited by 479
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“The discovery of somatostatin (71) and its ability to inhibit the endogenous release of glucagon (and insulin) (358, 359, 438) paved the way for additional clinical studies evaluating the role of endogenous glucagon in the development of chronic hyperglycemia and diabetes.”
BackgroundFUNCTIONAL SUBDIVISION OF ISLETS OF LANGERHANS AND POSSIBLE ROLE OF D CELLS
Orci, L., & Unger, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92078-4 · Cited by 414
Somatostatin receptors: From signaling to clinical practice
Theodoropoulou, M., & Stalla, G. K. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.07.005 · Cited by 410
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Insulin secretion in diabetes mellitus
Pfeifer, M. A., Halter, J. B., & Porte, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90579-9 · Cited by 367
Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., & Forsham, P. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505082921901 · Cited by 354
Hobart, P., Crawford, R., Shen, L., Pictet, R., & Rutter, W. J. (1980) · Nature · doi:10.1038/288137a0 · Cited by 339
“Somatostatinoma”: A Somatostatin-Containing Tumor of the Endocrine Pancreas
Ganda, O. P., Weir, G. C., Soeldner, J. S., Legg, M. A., Chick, W. L., Patel, Y. C., Ebeid, A. M., Gabbay, K. H., & Reichlin, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704282961703 · Cited by 290
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes.
Orci, L., Baetens, D., Rufener, C., Amherdt, M., Ravazzola, M., Studer, P., Malaisse-Lagae, F., & Unger, R. H. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1338 · Cited by 255
Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects
Sherwin, R. S., Fisher, M., Hendler, R., & Felig, P. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602262940901 · Cited by 252
Cherrington, A. D., Chiasson, J. L., Liljenquist, J. E., Jennings, A. S., Keller, U., & Lacy, W. W. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108596 · Cited by 249
“This finding is in agreement with earlier work carried out in vivo (21-24) and in vitro (25, 26).”
BackgroundResultGlucagon: Role in the Hyperglycemia of Diabetes Mellitus
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., & Unger, R. (1975) · Science · doi:10.1126/science.1089999 · Cited by 229
Intra-Islet Somatostatin Regulates Glucagon Release via Type 2 Somatostatin Receptors in Rats
Cejvan, K., Coy, D. H., & Efendic, S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1176 · Cited by 110
Insulin and glucagon as determinants of body weight set point and microregulation in rats
de Castro, J. M., Paullin, S. K., & DeLugas, G. M. (1978) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077485 · Cited by 74
Karimian, N., Qin, T., Liang, T., Osundiji, M., Huang, Y., Teich, T., Riddell, M. C., Cattral, M. S., Coy, D. H., Vranic, M., et al. (2013) · Diabetes · doi:10.2337/db13-0164 · Cited by 66
The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus
Sakurai, H., Dobbs, R. E., & Unger, R. H. (1975) · Metabolism · doi:10.1016/0026-0495(75)90067-0 · Cited by 62
Glucagon, from past to present: a century of intensive research and controversies
Scheen, A. J., & Lefèbvre, P. J. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00349-7 · Cited by 44
Metadata
- Authors
- Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J., & Gale, C. C.
- Venue
- Science
- Published
- 1974-04-26
- Volume
- 184
- Issue
- 4135
- Pages
- 482-484
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1996876777
- Cited by
- 519
- References
- 13
- FWCI
- 92.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.